• USFDA Approves First Dissolving Stent for Coronary Artery Disease Patient Undergoing Angioplasty.

    USFDA News Release, July 5, 2016.

    Cardiac Surgeons mostly treat coronary artery disease with a procedure called angioplasty to widen the artery using a metal stent. This drug-eluting stents temporarily release a drug (Everolimus), which helps in preventing rejection of organ transplant along with scar formation in the coronary artery. USFDA granted permission to the first absorbable heart stent known as poly L-lactide like sutures (GT1 bioresorbable vascular scaffold system), manufactured by Abbott Vascular in Santa Clara, California. A randomized controlled trial (RCT) was conducted in 2008 patients comparing cardiac adverse events reports. Result showed that, there was significant lower rate of cardiac adverse incidence in test group (7.8%), compared to control group (6.1%).

    Categories: Doctors Daily

    Tags: , , , , ,

    Leave a Reply

    Your email address will not be published. Required fields are marked *